Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: life extension – Page 162

The man himself:

Blueprint is a public science experiment to determine whether it’s possible to stay the same biological age. This requires slowing down aging processes as much as possible and then reversing the aging that has happened. Currently my speed of aging is .76 (DunedinPACE). That means for every 365 days each year, I age 277 days. My goal is to remain the same age biologically for every 365 days that pass.

I openly share (for free!) my diet, exercise and other protocols so that others can benefit and try to improve upon what I’m doing. I also openly share my health data as data is better than human opinion at guiding decision making. You can find everything here: https://blueprint.bryanjohnson.co/

This video is a whirlwind tour of what my daily life looks like as my team and I are on this adventure.

On the surface, Blueprint may seem like something about health, wellness and aging. To me, it’s a philosophy.

Continue reading “Why I Am Spending Millions To Be 18 Again” | >

New video: Stephanie Dainow, Executive Director at Lifespan.io / Lifespan Extension Advocacy Foundation, at #RejuvenationStartupSummit 2022.

Stephanie speaks about Lifespan.io advocating for the development of medical technologies to rejuvenate aged tissues and organs.

Enjoy →

For more summit videos and regular updates, visit: youtube.com/user/foreverhealthyorg

Stephanie Dainow, Executive Director of Lifespan.io at Rejuvenation Startup Summit 2022.

Continue reading “Stephanie Dainow at Rejuvenation Startup Summit 2022” | >

In a study from the University of Auckland, scientists found a drug that can increase life span. The age-old quest for immortality has taken a step forward. The team that long-term treatment of healthy mice from middle age (one year) with a drug currently used to treat cancer can increase their lifespan by an average of 10% to around three years.

Read more | >

Tidbits:

This current experiment is 3 million dollars.

They want to do another one in October but it’s not funded yet.

They have not nailed down the October round yet but wish to do plasma exchange and cellular reprogramming.

They will kill some of the current experiment mice because they need to assess the health of organs directly.

Continue reading “Rapamycin, mTert, HSCT, Senolytic First Robust Rejuvenation Trial | Dr Aubrey de Grey 2 Ep 2” | >

The last few years have exceeded all expectations in terms of investment activity in longevity, but much more is needed to push the field forward. With more than 40 investments in the longevity field over the past three years, LongevityTech.fund is one of the world’s most active longevity investment funds. The fund’s wide-ranging investment portfolio includes companies like BrainKey, Gerostate Alpha and Occuity.

LongevityTech.fund is now accepting new investors for its second fund, with a target fund size of $50 million up to a maximum of $100 million USD.

Longevity. Technology: LongevityTech.fund has built an impressive company portfolio that has seen no failures to date, with one IPO (longevity biotech Genflow Biosciences) and one company (longevity risk management firm Vesttoo) recently becoming the fund’s first unicorn (valued at more than $1 billion). To learn more about his views on the longevity market, we spoke to serial entrepreneur and investor Petr Sramek, LongevityTech.fund’s co-founder and managing partner.

Read more | >

Healthy mutant gene in super-fit people can reverse the decline of heart performance in the elderly, according to a study.

Injecting the genes of so-called “super-agers” into failing heart cells regenerates them, making them function as if they were 10 years younger, scientists have found.

The discovery opens the door for heart failure to be treated or prevented by reprogramming damaged cells.

Read more | >